BNY Mellon Strategic Municipals, Inc.
LEO · New York Stock Exchange · USD
6,09USD
−0,01 (−0,16 %)Stand 9. Nov., 21:00
Vortag 6,10
Kennzahlen
- Eröffnung
- 6,17
- Vortag
- 6,10
- Tagesspanne
- 6,075 – 6,17
- 52 Wochen
- 5,41 – 6,55
- Volumen
- 198.496
- Ø Volumen
- 241.983
Über das Unternehmen
BNY Mellon Strategic Municipals, Inc. is a closed ended fixed income mutual fund launched and managed by BNY Mellon Investment Adviser, Inc. It invests in the fixed income markets of the United States. The fund primarily invests in investment grade municipal bonds, the income from which is exempt from federal income tax. It employs fundamental analysis to create its portfolio. The fund was formerly known as Dreyfus Strategic Municipals, Inc. BNY Mellon Strategic Municipals, Inc. was formed on September 23, 1987 and is domiciled in the United States.
- CEO
- Roberto Cingolani
- Mitarbeitende
- 53.778
- Hauptsitz
- New York, NY, US
- Sektor
- Financial Services
- Branche
- Asset Management - Income
- Börsengang
- 23. Sept. 1987
Nachrichten
- GuruFocus · 8. Nov., 17:00Fibocom LTE Cat.1 bis Modules: Starlink DTC Field Test Report
- GuruFocus · 3. Nov., 10:00Digi International Announces Digi EX61 for Rugged, Indoor/Outdoor 5G Branch Connectivity
- Defense World · 27. Okt., 4:13BNY Mellon Strategic Municipals (NYSE:LEO) Major Shareholder Saba Capital Management, L.P. Acquires 65,000 Shares of Company Stock
- PRNewsWire · 20. Okt., 9:15Aviat Extends Mission-Critical Connectivity with LEO Satellite Integration
- GuruFocus · 15. Okt., 9:00Momentus Secures Commercial Contract with ARCSPACE to Advance In-Space Manufacturing
- 24/7 Wall Street · 6. Okt., 12:04AST SpaceMobile Is Soaring After State Dept. Endorses LEO Satellite Cooperation with Japan
- GuruFocus · 5. Okt., 10:00York Space Systems Expands into GEO to Support Space Domain Awareness Missions
- GuruFocus · 5. Okt., 4:00Redwire Awarded Follow-On Contract to Provide Roll-Out Solar Array Wings for Axiom Space's Second Space Station Module
- Business Wire · 1. Okt., 4:30LEO Pharma presents new tralokinumab data at EADV 2026 highlighting real-world outcomes and quality of life in adults and adolescents with atopic dermatitis (AD) involving high-burden areas
- Defense World · 30. Sept., 2:21BNY Mellon Strategic Municipals (NYSE:LEO) Stock Price Breaks Below 200 Day Moving Average – Time to Sell?
Kurse mindestens 15 Minuten verzögert. Daten: Financial Modeling Prep. Keine Anlageberatung.